Press releases
- FDA approves GSK’s BLENREP (belantamab mafodotin-blmf) for the treatment of patients with relapsed or refractory multiple myeloma
- GSK launches national public awareness campaign to reverse steep decline in already low immunization rates for adults
- Sanofi and GSK selected for Operation Warp Speed to supply United States Government with 100 million doses of COVID-19 vaccine
Tweets from GSK US
-
GSKUS @GSKUS
With this year’s #ATS2020 going virtual, Edwin, our Director of HCP Engagement is looking forward to connecting with a larger group of #respiratory HCPs. Join us for #ScienceOnTheSofa all week. 👉gsk.to/3fAl8HRT
about 1 hour ago
W
-
GSKUS @GSKUS
Calling #HCPs participating in this year’s virtual #ATS2020 – join Dr.Tom Corbridge and Sanjay Sethi as they discuss #COPD maintenance treatment approaches as part of a theatre session at 1:00 pm. Click below to visit the ATS virtual program for more information.
about 3 hours ago -
GSKUS @GSKUS
#Asthma is a chronic respiratory disease in which your airways narrow and swell, but not all asthma is the same. Click below to learn more about severe and symptomatic asthma and how you can better recognize the symptoms.
about 4 hours ago
